DORALIA FLORES: Open Payments
NPI 1629676044 · FREMONT, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,030 in 83 payments from 18 companies in 2025. Trend: 2023 $3,487 · 2024 $2,073 · 2025 $3,030
Food & beverage: $2,935Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $572 |
| Organogenesis Inc. | 15 | $468 |
| Amgen Inc. | 11 | $376 |
| Galderma Laboratories, L.P. | 6 | $265 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $247 |
| Janssen Biotech, Inc. | 3 | $235 |
| GENZYME CORPORATION | 5 | $211 |
| Incyte Corporation | 6 | $207 |
| REVANCE THERAPEUTICS, INC. | 2 | $158 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
Products named: OTEZLA, SKYRIZI, DUPIXENT, NEMLUVIO, TREMFYA, OPZELURA, RINVOQ, AFFINITY.
Industry payments across NE — which companies pay providers there.
